Target intelligence / Profile preview

Multimerin 2 pseudogene

Molecular classification
Pseudogene, Processed pseudogene
01

Overview

Multimerin 2 pseudogene (ENSG00000216906) is a processed pseudogene corresponding to the Multimerin 2 (MMRN2) gene. Processed pseudogenes are DNA elements derived from mRNA transcripts that have been reintegrated into the genome by reverse transcription and lack promoters, introns, and generally the ability to code for functional proteins. As such, this locus does not produce a functional protein product and is not considered a functional biological target. Pseudogenes like ENSG00000216906 may occasionally be transcribed into RNA but typically lack significant biological function. This pseudogene is not a receptor, enzyme, or therapeutic target, and does not have direct disease relevance or drug interactions. It should be noted that processed pseudogenes can sometimes complicate genetic analyses due to sequence similarity with their parent genes.

Other names
Multimerin 2 (MMRN2) pseudogeneENSG00000216906[3]
02

Mechanism of action

Not applicable

03

Biological functions

None (nonfunctional pseudogene—not translated into functional protein)
04

Disease associations

None (no direct disease association as a pseudogene)Other (pseudogenes in general can sometimes interfere with genetic studies or gene expression assays)
05

Safety considerations

None (no safety or toxicity concerns, but pseudogenes can complicate PCR assays or sequencing studies due to sequence similarity with functional genes)
06

Interacting drugs

None (as a pseudogene, there are no drugs interacting with this locus)
07

Biomarkers

None (not known to serve as a biomarker)

Beyond the preview

Go deeper on Multimerin 2 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multimerin 2 pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call